-
1
-
-
77149174778
-
Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of pseudomonas aeruginosa
-
Ham VH, Chang KT, Abdelrouf K, Brioso C.G., Ameka M., McCaskey LA, et al Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob Chemother 2010; 54:1160-1164.
-
(2010)
Antimicrob Chemother
, vol.54
, pp. 1160-1164
-
-
Ham, V.H.1
Chang, K.T.2
Abdelrouf, K.3
Brioso, C.G.4
Ameka, M.5
McCaskey, L.A.6
-
2
-
-
79955527743
-
Nosocomial blood stream infections in Brazilian hospitals: Analysis of 2,563 cases from a prospective nationwide surveillance study
-
(Brazilian SCOPE Study Group)
-
Marra AR, Camargo LF, Pignatari A.C., Sukienni KT, Bahar PR, Medeiros EA, et al (Brazilian SCOPE Study Group). Nosocomial blood stream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 2011; 49:1866-1871.
-
(2011)
J Clin Microbiol
, vol.49
, pp. 1866-1871
-
-
Marra, A.R.1
Camargo, L.F.2
Pignatari, A.C.3
Sukienni, K.T.4
Bahar, P.R.5
Medeiros, E.A.6
-
3
-
-
84872306777
-
Phenotypic and molecular characterization of antimicrobial resistance and virulence factors in pseudomonas aeruginosa clinical isolates from recife, state of pernambuco, Brazil
-
Jácome PRLA, Alves LR, Cabrai AB, Lopes ACS, Maciel MAV. Phenotypic and molecular characterization of antimicrobial resistance and virulence factors in Pseudomonas aeruginosa clinical isolates from Recife, State of Pernambuco, Brazil. Rev Soc Bras Med Tropical 2012; 45:707-712.
-
(2012)
Rev Soc Bras Med Tropical
, vol.45
, pp. 707-712
-
-
Jácome, P.R.L.A.1
Alves, L.R.2
Cabrai, A.B.3
Lopes, A.C.S.4
Maciel, M.A.V.5
-
4
-
-
84863654489
-
Combination therapy for treatment of infections with gram-negative bacteria
-
Tamma PD, Cosgrove SE, Maragakis LL Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 2012;25:450-470.
-
(2012)
Clin Microbiol Rev
, vol.25
, pp. 450-470
-
-
Tamma, P.D.1
Cosgrove, S.E.2
Maragakis, L.L.3
-
5
-
-
84455192457
-
Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for pseudomonas aeruginosa
-
Drusano GL, Bonomo RA, Bahnink N, Bulitta J.B., Vanscoy B., DeFiglio H, et al Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa. Antimicrob Ag Chemother 2012; 56:231-242.
-
(2012)
Antimicrob Ag Chemother
, vol.56
, pp. 231-242
-
-
Drusano, G.L.1
Bonomo, R.A.2
Bahnink, N.3
Bulitta, J.B.4
Vanscoy, B.5
DeFiglio, H.6
-
7
-
-
14944362740
-
Performance standards for antimicrobial susceptibility testing
-
Clinical and Laboratory Standards Institute (CLSI) Wayne, PA, USA: CLSI
-
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement M100-S20. Wayne, PA, USA: CLSI; 2010.
-
(2010)
Twentieth Informational Supplement M100-S20
-
-
-
8
-
-
77957874402
-
-
[Software]. EUCAST [Version 3.0]
-
European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoints tables for interpretation of MICs and zone diameters [Software]. EUCAST 2013. [Version 3.0]. Available from: http://www.eucast.org/clinical- breakpoints/.
-
(2013)
Breakpoints Tables for Interpretation of MICs and Zone Diameters
-
-
-
9
-
-
70350279548
-
Comparison of the methods to test antibiotic combinations against heterogeneous populations of multiresistant pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis
-
Foweraker JE, Laughton CR, Brown D.F., Bilton D. Comparison of the methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis. Antimicrob Ag Chemother 2009;53:4809-4815.
-
(2009)
Antimicrob Ag Chemother
, vol.53
, pp. 4809-4815
-
-
Foweraker, J.E.1
Laughton, C.R.2
Brown, D.F.3
Bilton, D.4
-
10
-
-
70450199336
-
Role of old antibiotics in multidrug resistant bacterial infections
-
Maviglia R, Nestorini R, Pennisi M. Role of old antibiotics in multidrug resistant bacterial infections. Curr Drug Targets 2009; 10:895-905.
-
(2009)
Curr Drug Targets
, vol.10
, pp. 895-905
-
-
Maviglia, R.1
Nestorini, R.2
Pennisi, M.3
-
11
-
-
34548401552
-
Intravenous polymyxin for the treatment of nosocomial pneumonia caused by multidrug-resistant pseudomonas aeruginosa
-
Furtado GH, D'Azevedo PA, Santos AF, Gales A.C., Pignatari AC, Medeiros EA Intravenous polymyxin for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Int J Antimicrob Agents 2007; 30:315-319.
-
(2007)
Int J Antimicrob Agents
, vol.30
, pp. 315-319
-
-
Furtado, G.H.1
D'Azevedo, P.A.2
Santos, A.F.3
Gales, A.C.4
Pignatari, A.C.5
Medeiros, E.A.6
-
12
-
-
77953273374
-
Antimicrobial susceptibility of gram-negative non urinary bacteria to fosfomycin and other antimicrobials
-
Samonis G, Maraki S, Rafailidis P.I., Kaspaskelis A., Kastoris AC, Falagas ME Antimicrobial susceptibility of Gram-negative non urinary bacteria to fosfomycin and other antimicrobials. Future Microbiol 2010; 5: 961-970.
-
(2010)
Future Microbiol
, vol.5
, pp. 961-970
-
-
Samonis, G.1
Maraki, S.2
Rafailidis, P.I.3
Kaspaskelis, A.4
Kastoris, A.C.5
Falagas, M.E.6
-
13
-
-
79951875467
-
Pseudomonas aeruginosa fosfomycin resistance mechanisms affect noninherited fluoroquinolone tolerance
-
De Groote V.N., Faunart M, Kint C.L., Verstaetein N., Jans A, Cornells P, et al Pseudomonas aeruginosa fosfomycin resistance mechanisms affect noninherited fluoroquinolone tolerance. J Med Microbiol 2011; 60: 329-336.
-
(2011)
J Med Microbiol
, vol.60
, pp. 329-336
-
-
De Groote, V.N.1
Faunart, M.2
Kint, C.L.3
Verstaetein, N.4
Jans, A.5
Cornells, P.6
-
14
-
-
77956325563
-
Assessing the emergence of resistance: The absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections
-
Rodriguez-Rojas A., Maciá MD, Couce A, Goméz C, Castañeda-Garcia A, Oliver A, et al. Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections. PloS One 2010; 5: e10193.
-
(2010)
PloS One
, vol.5
-
-
Rodriguez-Rojas, A.1
Maciá, M.D.2
Couce, A.3
Goméz, C.4
Castañeda-Garcia, A.5
Oliver, A.6
-
15
-
-
0141997696
-
Dissemination in distint Brazilian regions of an epidemic carbapenem-resistant pseudomonas aeruginosa producing SPM metallo-beta-lactamase
-
Gales AC, Menezes LC, Silbert S, Sader HS Dissemination in distint Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J Infect Chemother 2003; 52:699-702.
-
(2003)
J Infect Chemother
, vol.52
, pp. 699-702
-
-
Gales, A.C.1
Menezes, L.C.2
Silbert, S.3
Sader, H.S.4
-
16
-
-
32644481380
-
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strain pseudomonas aeruginosa and acinetobacter baumannii isolated from intensive care units
-
Timurkaynak F, Can F, Azap O.K., Demirbilek M., Arslan H, Karaman SO In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strain Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 2006; 27:224-228.
-
(2006)
Int J Antimicrob Agents
, vol.27
, pp. 224-228
-
-
Timurkaynak, F.1
Can, F.2
Azap, O.K.3
Demirbilek, M.4
Arslan, H.5
Karaman, S.O.6
-
17
-
-
75749107905
-
In vitro efficacy of synergistic antibiotic combinations in multidrug resistant pseudomonas aeruginosa strains
-
Dundar D, Otkum M. In vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains. Yonsei Med J 2010;51:111-116.
-
(2010)
Yonsei Med J
, vol.51
, pp. 111-116
-
-
Dundar, D.1
Otkum, M.2
-
18
-
-
67349240825
-
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting gram-negative bacilli: A systematic review of microbiological, animal and clinical studies
-
Falagas MF, Kastoris AC, Karageouropoulos D.E., Rafailidis P. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents 2009; 34:111-120.
-
(2009)
Int J Antimicrob Agents
, vol.34
, pp. 111-120
-
-
Falagas, M.F.1
Kastoris, A.C.2
Karageouropoulos, D.E.3
Rafailidis, P.4
-
19
-
-
84857186407
-
Fosfomycin enhances the active transport of tobramycin in pseudomonas aeruginosa
-
MacLeod DL, Velayudhan J, Kenney T.F., Therrien JH, Sutherland JL, Barker LM, et al Fosfomycin enhances the active transport of tobramycin in Pseudomonas aeruginosa. Antimicrob Ag Chemother 2012; 56:1529-1538.
-
(2012)
Antimicrob Ag Chemother
, vol.56
, pp. 1529-1538
-
-
MacLeod, D.L.1
Velayudhan, J.2
Kenney, T.F.3
Therrien, J.H.4
Sutherland, J.L.5
Barker, L.M.6
-
20
-
-
30344461017
-
In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant pseudomonas aeruginosa
-
Pruekpreasert P, Tumiapanit W. In vitro activity of fosfomycin- gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime- gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa. Southeast Asian Trop Med Publ Health 2005; 36:1239-1242.
-
(2005)
Southeast Asian Trop Med Publ Health
, vol.36
, pp. 1239-1242
-
-
Pruekpreasert, P.1
Tumiapanit, W.2
-
21
-
-
34147214218
-
Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of pseudomonas aeruginosa
-
Yamada S, Hyo Y, Ohuori M. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa. Chemotherapy 2007; 53:202-209.
-
(2007)
Chemotherapy
, vol.53
, pp. 202-209
-
-
Yamada, S.1
Hyo, Y.2
Ohuori, M.3
-
22
-
-
0023274446
-
Synergy of impenem - A novel carbapenem, and rifampin and ciprofloxacin against pseudomonas aeruginosa, serratia marcescens and enterobacter species
-
Chin NX, Neu HC Synergy of impenem - a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species. Chemotherapy 1987; 33:183-188.
-
(1987)
Chemotherapy
, vol.33
, pp. 183-188
-
-
Chin, N.X.1
Neu, H.C.2
-
23
-
-
0025323118
-
The effect of rifampicin on the in vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against pseudomonas aeruginosa
-
Valdes JM, Baltch AL, Smith R.P., Hammer MC, Ritz WJ The effect of rifampicin on the in vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa. J Antimicrob Chemother 1990; 25:575-584.
-
(1990)
J Antimicrob Chemother
, vol.25
, pp. 575-584
-
-
Valdes, J.M.1
Baltch, A.L.2
Smith, R.P.3
Hammer, M.C.4
Ritz, W.J.5
-
24
-
-
0029896104
-
The effect of rifampicin on adaptative resistance of pseudomonas aeruginosa to aminoglycosides
-
Xiong YQ, Caillon J, Drugcon H., Potel G, Baron D. The effect of rifampicin on adaptative resistance of Pseudomonas aeruginosa to aminoglycosides. J Antimicrob Chemother 1996; 37:993-998.
-
(1996)
J Antimicrob Chemother
, vol.37
, pp. 993-998
-
-
Xiong, Y.Q.1
Caillon, J.2
Drugcon, H.3
Potel, G.4
Baron, D.5
-
26
-
-
0028828457
-
Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by pseudomonas aeruginosa
-
Weiss K, Lapointe JR Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa. Antimicrob Ag Chemother 1995; 39:2411-2414.
-
(1995)
Antimicrob Ag Chemother
, vol.39
, pp. 2411-2414
-
-
Weiss, K.1
Lapointe, J.R.2
-
27
-
-
44949084345
-
In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distint multidrug-resistant isolates of pseudomonas aeruginosa
-
Kanellakopoulou K, Sarafis P, Galani I., Giamarellou H, Giamarellos-Bourboulis EJ. In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distint multidrug-resistant isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 2008; 32:33-39.
-
(2008)
Int J Antimicrob Agents
, vol.32
, pp. 33-39
-
-
Kanellakopoulou, K.1
Sarafis, P.2
Galani, I.3
Giamarellou, H.4
Giamarellos-Bourboulis, E.J.5
-
28
-
-
77749243224
-
Quantitative assestment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model
-
Yuan Z, Ledesma KR, Singh R, Prince R.A., Tam VH Quantitative assestment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model. J Infect Dis 2010; 201:889-897.
-
(2010)
J Infect Dis
, vol.201
, pp. 889-897
-
-
Yuan, Z.1
Ledesma, K.R.2
Singh, R.3
Prince, R.A.4
Tam, V.H.5
|